Lumenis Ltd. Announces Pricing of Its Initial Public Offering
27 févr. 2014 10h30 HE
|
Lumenis
YOKNEAM, ISRAEL--(Marketwired - Feb 27, 2014) - Lumenis Ltd. today announced the pricing of its initial public offering of 6,250,000 ordinary B shares at a price of $12.00 per share. In addition,...
Lumenis Ltd. Announces Launch of Initial Public Offering
13 févr. 2014 19h14 HE
|
Lumenis
YOKNEAM, ISRAEL--(Marketwired - Feb 13, 2014) - Lumenis Ltd. today announced that it has commenced an initial public offering of 6,250,000 ordinary B shares pursuant to a registration statement...
Lumenis Files Registration Statement for Proposed Public Offering and NASDAQ Listing
09 déc. 2013 09h10 HE
|
Lumenis
YOKNEAM, ISRAEL--(Marketwired - Dec 9, 2013) - Lumenis Ltd., a leading global provider of minimally invasive clinical solutions for surgical, ophthalmic and aesthetic applications, today announced...
Lumenis Receives US FDA and Japanese MHLW Clearance for Array(TM) LaserLink(TM) Pattern Scanning Device for Multi-Spot Retinal Laser Treatment
15 nov. 2013 01h00 HE
|
Lumenis
SAN JOSE, CA--(Marketwired - Nov 15, 2013) - Lumenis Ltd., the world's largest medical laser company for ophthalmic, surgical and aesthetic applications, today announced that the company has...
Lumenis Introduces Powerful New Solution for Killer Abdominal Cramps
16 oct. 2013 03h00 HE
|
Lumenis
YOKNEAM, ISRAEL--(Marketwired - Oct 16, 2013) - Killer cramps can be a thing of the past for women with conditions such as endometriosis, adhesions and uterine fibroids. Lumenis Ltd., the...
Lumenis Introduces Next-Generation CO2 Laser, the AcuPulse(TM) DUO: Empowering Surgeons With Ultimate Flexibility of Both Fiber & Free Beam Modalities on a Single Platform
23 sept. 2013 09h00 HE
|
Lumenis
VANCOUVER, BC--(Marketwired - Sep 23, 2013) - Lumenis Ltd., the world's largest medical laser company for surgical, ophthalmic, and aesthetic applications, announced today the introduction of the...
Lumenis Receives FDA Clearance for ResurFX(TM), New Fractional Non-Ablative Module for M22(TM) Aesthetic Platform
16 sept. 2013 09h00 HE
|
Lumenis
YOKNEAM, ISRAEL--(Marketwired - Sep 16, 2013) - Lumenis Ltd., the world's largest medical laser company for ophthalmic, surgical and aesthetic applications, today announced that the Company has...
Lumenis Expands Its Product Line in China Through Strategic Partnership With Visionix
25 juil. 2013 09h00 HE
|
Lumenis
SAN JOSE, CA and JERUSALEM--(Marketwired - Jul 25, 2013) - Lumenis Ltd., the world's largest medical laser company for ophthalmic, aesthetic, and surgical applications, and Visionix, a worldwide...
New Study by Dr. Tony Realini Demonstrates Lumenis SLT as a Powerful Tool for Reducing Glaucoma-Related Blindness in the Developing World
11 juin 2013 09h00 HE
|
Lumenis
SAN JOSE, CA--(Marketwired - Jun 11, 2013) - Lumenis Ltd. announced today that the company is pledging its support to the work of Tony Realini, MD, MPH, Associate Professor of Ophthalmology, West...
Lumenis(R) Supports Prestigious Moorfields Eye Hospital in Seminal Glaucoma Study Using Lumenis' Selective Laser Trabeculoplasty (SLT) Technology
07 mai 2013 04h00 HE
|
Lumenis
SAN JOSE, CA--(Marketwired - May 7, 2013) - Lumenis Ltd., the world's largest medical laser company for ophthalmic, aesthetic, and surgical applications, and the pioneer of Selective Laser...